Hillary Millar Quinn

About Hillary Millar Quinn

I am an accomplished leader in nonclinical drug development with 25 years of experience across biotechnology, large pharmaceutical, and CRO environments. I bring strategic leadership and scientific expertise in CGT, small and large molecules, and bispecific antibodies, to advance transformational medicines and innovative therapies for patients. Known for being highly organized and results-driven, I excel at operational leadership, and building strong cross-functional partnerships to align teams and achieve organizational objectives. I am passionate about improving patient outcomes through the translation of cutting-edge science and my contributions to early development.

Experience

1. Assistant Director Scientific Development, Early Development

   Labcorp

   Mar 2025 — Present · Philadelphia, PA, US

   Lead cross-functional collaboration with Business Development and Operations to identify and engage internal resources, guiding clients through the successful development of drug candidates.Drive internal R&D and external initiatives with a focus on ADCs, bispecific antibodies, and CGT, partnering with Marketing and Business Development to expand the impact and growth of the Scientific Development team and Discovery Oncology services.Represent the organization at industry workshops and conferences, translating external insights into strategic advancements for internal assay development and drug development initiatives.

Education

• Jefferson Health

  M.S., Pharmacology

  2003 — 2007

• Delaware Valley University

  B.S., Small Animal Science

  1997 — 2001

Skills

• Cell
• Scientific Writing
• Drug Discovery
• Biomarker Discovery
• Pharmaceutical Industry
• Clinical Development
• Tumor Immunology
• Immunology
• Biochemistry
• Protein Chemistry
• Pharmacology
• Animal Models
• Translational Medicine
• Antibodies
• Biotechnology
• Oncology
• Life Sciences
• In Vivo
• Cancer
• Small Animal Imaging
• Glp
• Sharepoint
• Toxicology
• Biomarkers